HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yazdan Yazdanpanah Selected Research
Yazdan Yazdanpanah Research Topics
Disease
35
Infections
01/2022 - 08/2006
22
COVID-19
06/2022 - 01/2020
15
HIV Infections (HIV Infection)
01/2022 - 12/2002
6
Osteomyelitis
10/2010 - 10/2004
5
Fibrosis (Cirrhosis)
01/2017 - 01/2013
5
Acquired Immunodeficiency Syndrome (AIDS)
09/2012 - 12/2002
4
Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
06/2022 - 01/2016
4
Coinfection
01/2022 - 07/2015
4
Ebola Hemorrhagic Fever
01/2021 - 11/2015
4
Disease Progression
01/2020 - 01/2005
4
Hepatitis C
10/2018 - 02/2012
3
Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2021 - 01/2010
3
Communicable Diseases (Infectious Diseases)
02/2017 - 02/2004
3
Human Influenza (Influenza)
03/2016 - 10/2009
3
Viremia
03/2016 - 11/2009
3
Neoplasms (Cancer)
06/2008 - 10/2007
2
Bacterial Infections (Bacterial Infection)
01/2022 - 02/2020
2
Tuberculosis (Tuberculoses)
01/2022 - 03/2016
2
Pneumonia (Pneumonitis)
01/2022 - 09/2020
2
Chronic Renal Insufficiency
01/2022 - 01/2016
2
Critical Illness (Critically Ill)
09/2020 - 09/2012
2
Inflammation (Inflammations)
01/2019 - 01/2019
2
Abscess
01/2019 - 04/2015
2
Hypertension (High Blood Pressure)
01/2019 - 07/2011
2
Hepatitis B
01/2019 - 11/2017
2
Nausea
01/2019 - 11/2017
2
Headache (Headaches)
01/2019 - 11/2017
2
Substance-Related Disorders (Drug Abuse)
01/2019 - 04/2015
2
Chronic Hepatitis C
11/2016 - 01/2016
2
Liver Cirrhosis (Hepatic Cirrhosis)
01/2013 - 02/2012
2
Peripheral Nervous System Diseases (PNS Diseases)
10/2010 - 08/2006
2
Thrombocytopenia (Thrombopenia)
10/2010 - 10/2004
2
Catheter-Related Infections
03/2009 - 10/2007
2
Opportunistic Infections (Opportunistic Infection)
01/2007 - 03/2003
1
Drug-Related Side Effects and Adverse Reactions
06/2022
1
Thrombosis (Thrombus)
01/2022
1
Hepatorenal Syndrome
01/2022
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022
Drug/Important Bio-Agent (IBA)
11
Pharmaceutical Preparations
IBA
06/2022 - 11/2009
8
RNA (Ribonucleic Acid)
IBA
01/2022 - 01/2005
7
Antiviral Agents (Antivirals)
IBA
01/2022 - 10/2009
7
Anti-Bacterial Agents (Antibiotics)
IBA
04/2020 - 10/2004
6
Vaccines
IBA
06/2022 - 04/2011
5
Nucleosides
IBA
01/2022 - 05/2007
5
Ritonavir (Norvir)
FDA Link
12/2021 - 11/2003
5
Rilpivirine (TMC-278)
IBA
09/2021 - 01/2015
4
Linezolid (Zyvox)
FDA Link
06/2022 - 10/2004
4
Raltegravir Potassium
FDA Link
01/2022 - 10/2009
4
Reverse Transcriptase Inhibitors
IBA
01/2022 - 05/2007
4
remdesivir
IBA
01/2022 - 01/2020
4
Protease Inhibitors (Protease Inhibitor)
IBA
01/2022 - 05/2007
4
Biological Products
IBA
01/2021 - 02/2004
4
Lamivudine (Epivir)
FDA Link
01/2021 - 01/2007
4
Emtricitabine (Emtriva)
FDA Link
01/2019 - 01/2017
4
bedaquiline (R207910)
IBA
01/2018 - 01/2016
4
Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)
FDA Link
Generic
01/2018 - 08/2005
4
Tenofovir (Viread)
FDA Link
11/2017 - 01/2017
3
Rifampin (Rifampicin)
FDA Link
Generic
01/2022 - 10/2010
3
Ribavirin (Virazole)
FDA Link
Generic
01/2022 - 07/2015
3
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
12/2021 - 01/2020
3
Antigens
IBA
11/2021 - 07/2020
3
Alanine Transaminase (SGPT)
IBA
09/2020 - 01/2013
3
Biomarkers (Surrogate Marker)
IBA
01/2017 - 01/2007
3
Zidovudine (Retrovir)
FDA Link
Generic
07/2016 - 01/2007
2
dolutegravir
IBA
01/2022 - 01/2019
2
Enzymes
IBA
01/2022 - 01/2013
2
efavirenz (Sustiva)
FDA Link
01/2022 - 03/2011
2
Lopinavir
FDA Link
12/2021 - 11/2003
2
cabotegravir
IBA
09/2021 - 09/2017
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2021 - 01/2021
2
Interferons
IBA
01/2020 - 07/2015
2
Silicones
IBA
01/2019 - 01/2019
2
OPC-67683
IBA
01/2018 - 03/2016
2
Sofosbuvir
IBA
11/2016 - 01/2016
2
favipiravir
IBA
04/2016 - 03/2016
2
Vancomycin
FDA Link
Generic
06/2011 - 03/2009
2
Calcium
IBA
12/2009 - 04/2008
2
fosamprenavir (Lexiva)
FDA Link
11/2008 - 01/2007
2
A-factor (Streptomyces)
IBA
04/2008 - 08/2007
1
Immunoglobulin G (IgG)
IBA
06/2022
1
Neutralizing Antibodies
IBA
06/2022
1
BNT162 Vaccine
IBA
06/2022
1
Oxygen (Dioxygen)
IBA
01/2022
1
Prothrombin (Factor II)
IBA
01/2022
1
Integrases
IBA
01/2022
1
Interferon beta-1a
FDA Link
01/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Ketamine
FDA Link
Generic
01/2021
Therapy/Procedure
28
Therapeutics
01/2022 - 03/2003
6
Highly Active Antiretroviral Therapy (HAART)
01/2018 - 12/2002
2
Length of Stay
01/2021 - 06/2008
2
Aftercare (After-Treatment)
01/2020 - 01/2017
2
Condoms (Condom)
01/2018 - 03/2013
2
Art Therapy
01/2017 - 01/2010
2
Catheters
03/2009 - 10/2007
2
Antibiotic Prophylaxis
03/2009 - 08/2007
1
Mechanical Ventilators (Ventilator)
01/2022
1
Contraindications
01/2022
1
Continuity of Patient Care
01/2022
1
Personal Protective Equipment
01/2021